# Writing to Alleviate Violence Exposure for Transgender Women (WAVE-TW)

> **NCT04305977** · NA · WITHDRAWN · sponsor: **University of Miami**

## Conditions studied

- PTSD
- Depression
- Virus, Human Immunodeficiency

## Interventions

- **BEHAVIORAL:** WAVE-TW

## Key facts

- **NCT ID:** NCT04305977
- **Lead sponsor:** University of Miami
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-10-22
- **Primary completion:** 2021-10-15
- **Final completion:** 2021-10-15
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** There was enrollment in the qualitative phase that proceeded this planned open pilot trial. However, community partner experienced barriers to recruitment and enrollment in the context of COVID and needed prioritize non-research functions.
- **Last updated:** 2023-02-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04305977

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04305977, "Writing to Alleviate Violence Exposure for Transgender Women (WAVE-TW)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04305977. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*